
Aug 2026 Advisory Council on Alzheimer’s Research, Care, and Services Meeting | August 3, Part 4

During the third meeting of 2026, the Advisory Council will hear from a panel organized by the research subcommittee; updates from federal agencies, including an overview of the authorities of the National Institutes of Health, the Food and Drug Administration, and the Centers for Medicare & Medicaid Services; legislative updates from advocacy groups; and an update on the Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease (REMIND) Study. Advisory Council subcommittees will also present their recommendations for adoption by the full Advisory Council.
---
U.S. Department of Health and Human Services (HHS)
http://www.hhs.gov
HHS Privacy Policy
Video Summary
AI GeneratedThis meeting addressed public comments on the national plan for Alzheimer's Disease and Related Dementias (ADRD). Advocacy groups emphasized the need for legal protections for asymptomatic individuals, specialized recognition and care for Frontotemporal Degeneration (FTD) and Lewy Body Dementia (LBD), and systemic reforms to prevent medication errors and discrimination.
